Search Results

There are 7324 results for: content related to: Identification and characterization of mutations in hepatitis B virus resistant to lamivudine

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Article first published online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  2. Should lamivudine monotherapy be stopped or continued in patients infected with hepatitis B with favorable responses after more than 5 years of treatment?

    Journal of Medical Virology

    Volume 85, Issue 1, January 2013, Pages: 34–42, Jung Hyun Kwon, Jeong Won Jang, Jong Young Choi, Chung-Hwa Park, Sun Hong Yoo, Si Hyun Bae and Seung Kew Yoon

    Article first published online : 14 NOV 2012, DOI: 10.1002/jmv.23421

  3. Management of viral hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 17, Issue s1, February 2002, Pages: S125–S145, CHUTIMA PRAMOOLSINSUP

    Article first published online : 8 MAY 2002, DOI: 10.1046/j.1440-1746.17.s1.3.x

  4. Management of chronic hepatitis B virus infection: a new era of disease control

    Internal Medicine Journal

    Volume 36, Issue 2, February 2006, Pages: 100–113, G. C. Farrell and N. C. Teoh

    Article first published online : 10 FEB 2006, DOI: 10.1111/j.1445-5994.2006.01027.x

  5. You have free access to this content
    Efficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen–negative/hepatitis B virus DNA–positive (precore mutant) chronic hepatitis BB

    Hepatology

    Volume 29, Issue 3, March 1999, Pages: 889–896, Nicolaos C. Tassopoulos, Riccardo Volpes, Giuseppe Pastore, Jenny Heathcote, Maria Buti, Robert D. Goldin, Sasha Hawley, Judy Barber, Lynn Condreay and D. Fraser Gray

    Article first published online : 30 DEC 2003, DOI: 10.1002/hep.510290321

  6. Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment

    Hepatology Research

    Volume 40, Issue 2, February 2010, Pages: 125–134, Mariko Kobayashi, Fumitaka Suzuki, Norio Akuta, Hiromi Yatsuji, Tetsuya Hosaka, Hitomi Sezaki, Masahiro Kobayashi, Yusuke Kawamura, Yoshiyuki Suzuki, Yasuji Arase, Kenji Ikeda, Rie Mineta, Satomi Iwasaki, Sachiyo Watahiki and Hiromitsu Kumada

    Article first published online : 25 SEP 2009, DOI: 10.1111/j.1872-034X.2009.00565.x

  7. You have free access to this content
    AASLD Abstracts 895–1142

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 707A–816A,

    Article first published online : 24 SEP 2008, DOI: 10.1002/hep.22644

  8. YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine

    Journal of Viral Hepatitis

    Volume 10, Issue 4, July 2003, Pages: 256–265, A. M. Bozdayi̇, Ö. Uzunalimoğlu, A. R. Türkyi̇lmaz, N. Aslan, O. Sezgin, T. Sahin, G. Bozdayi̇, K. Çi̇nar, S. B. Pai, R. Pai, H. Bozkaya, S. Karayalçi̇n, C. Yurdaydi̇n and R. F. Schinazi

    Article first published online : 23 JUN 2003, DOI: 10.1046/j.1365-2893.2003.00435.x

  9. Abstract Index

    Journal of Gastroenterology and Hepatology

    Volume 19, Issue s7, December 2004, Pages: A676–A868,

    Article first published online : 3 DEC 2004, DOI: 10.1111/j.1440-1746.2004.03735.x

  10. You have free access to this content
    Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy

    Hepatology

    Volume 34, Issue 4, October 2001, Pages: 785–791, Man-Fung Yuen, Erwin Sablon, Prof. Chee-Kin Hui, He-Jun Yuan, Hilde Decraemer and Ching-Lung Lai

    Article first published online : 30 DEC 2003, DOI: 10.1053/jhep.2001.27563

  11. Management of Drug-Resistant Mutants

    Viral Hepatitis, Third Edition

    Howard Thomas, Stanley Lemon, Arie Zuckerman, Pages: 337–344, 2007

    Published Online : 26 OCT 2007, DOI: 10.1002/9780470987131.ch21

  12. Efficacy of switching to entecavir monotherapy in Japanese lamivudine-pretreated patients

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 5, May 2010, Pages: 892–898, Fumitaka Suzuki, Norio Akuta, Yoshiyuki Suzuki, Hiromi Yatsuji, Hitomi Sezaki, Yasuji Arase, Miharu Hirakawa, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Kenji Ikeda, Mariko Kobayashi, Sachiyo Watahiki and Hiromitsu Kumada

    Article first published online : 30 OCT 2009, DOI: 10.1111/j.1440-1746.2009.06161.x

  13. You have free access to this content
    Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus–infected patients

    Hepatology

    Volume 30, Issue 5, November 1999, Pages: 1302–1306, Yves Benhamou, Marie Bochet, Vincent Thibault, Vincent Di Martino, Eric Caumes, François Bricaire, Pierre Opolon, Christine Katlama and Thierry Poynard

    Article first published online : 30 DEC 2003, DOI: 10.1002/hep.510300525

  14. APASL Abstracts, Bali 2005

    Liver International

    Volume 25, Issue 6, December 2005, Pages: 1270–1384,

    Article first published online : 11 NOV 2005, DOI: 10.1111/j.1478-3231.2005.01182.x

  15. Four years of lamivudine treatment in Chinese patients with chronic hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 19, Issue 11, November 2004, Pages: 1276–1282, TING-TSUNG CHANG, CHING-LUNG LAI, RONG-NAN CHIEN, RICHARD GUAN, SENG-GEE LIM, CHUAN-MO LEE, KENG-YEEN NG, GRAHAM J NICHOLLS, JULIE C DENT and NANCY WY LEUNG

    Article first published online : 11 JUN 2004, DOI: 10.1111/j.1440-1746.2004.03428.x

  16. You have free access to this content
    YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitrofull-length viral DNA transfection

    Hepatology

    Volume 29, Issue 3, March 1999, Pages: 939–945, Suzane Kioko Ono-Nita, Naoya Kato, Yasushi Shiratori, Tsutomu Masaki, Keng-Hsin Lan, Flair José Carrilho and Masao Omata

    Article first published online : 30 DEC 2003, DOI: 10.1002/hep.510290340

  17. You have free access to this content
    Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapy

    Hepatology

    Volume 31, Issue 6, June 2000, Pages: 1318–1326, Chau-Ting Yeh, Rong-Nan Chien, Chia-Ming Chu and Yun-Fan Liaw

    Article first published online : 30 DEC 2003, DOI: 10.1053/jhep.2000.7296

  18. Viral Hepatitis

    Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition

    Mario Rizzetto, Fabien Zoulim, Pages: 819–956, 2008

    Published Online : 15 APR 2008, DOI: 10.1002/9780470691861.ch9a

  19. Favorable efficacy of long-term lamivudine therapy in patients with chronic hepatitis B: An 8-year follow-up study

    Journal of Medical Virology

    Volume 75, Issue 4, April 2005, Pages: 491–498, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Hitomi Sezaki, Tetsuya Hosaka, Takashi Someya, Masahiro Kobayashi, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi and Hiromitsu Kumada

    Article first published online : 15 FEB 2005, DOI: 10.1002/jmv.20305

  20. Lamivudine treatment of chronic hepatitis B

    Reviews in Medical Virology

    Volume 8, Issue 3, July/September 1998, Pages: 153–159, Geoffrey Dusheiko

    Article first published online : 4 MAY 1999, DOI: 10.1002/(SICI)1099-1654(199807/09)8:3<153::AID-RMV228>3.0.CO;2-Y